Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Radiotherapy

 

Investors for Health opens door to all serious emerging market investors

All emerging market health-care investors are welcome to join Investors for Health (I4H), a newish community of 30+ investors including development banks, private equity, venture capital and impact funds. The group aims to jointly focus on private healthcare development in emerging markets with a focus on equity and alignment with universal healthcare cover. It next meets at HBI 2020, April 20-22, London. Its formation reflects a quiet revolution in the role of for-profit healthcare and its importance in bridging the World Health Organisation's estimated $686bn funding gap in low-and-middle-income countries to achieve the United Nation’s Sustainable Development Goal #3 (“Ensure healthy lives and promote well-being for all at all ages”).

Interview: Stefan Klussmann, co-founder of Planerio

Poor scheduling, especially in DRG funded models, can be financially devastating if it leads to closed facilities and wasted patient appointments. What solutions are available to the market? HBI speaks to the founder of one automated scheduling solution, Planerio, about keeping MRIs running through M&A, complying with the law and Germany's workforce shortage.

MedEuropa enters French market

Pan-European radiotherapy group MedEuropa has entered the French market by acquiring a radiotherapy clinic on the site of an Elsan hospital. HBI speaks to CEO Ralph Hefti.

Interview: Thierry Chiche, CEO, Elsan

HBI talks to the CEO of Elsan, France's second-largest private hospital group and the largest private equity-owned one by revenue outside of the US, as it approaches its sixth - and possibly final - year of ownership by CVC. In this wide-ranging interview, Chiche discusses the group's strategy, the French market and exclusively reveals its latest acquisition.

Life’s Polish pullout points to wider woes in market

Life Healthcare confirmed last week that it was looking to exit its Polish hospital business, Scanmed, citing further regulatory changes. Other investors are also looking to leave the country and assets that were expected to sell remain unsold. What went wrong in a market we once described as "stuff as dreams are made of"?

FREE BLOG New HBI pipeline tool reveals long-held investments 

Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.

Find Us